699 related articles for article (PubMed ID: 26119045)
1. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.
Vallières M; Freeman CR; Skamene SR; El Naqa I
Phys Med Biol; 2015 Jul; 60(14):5471-96. PubMed ID: 26119045
[TBL] [Abstract][Full Text] [Related]
2. SU-D-BRB-03: Prediction of Tumor Outcomes Through Wavelet Image Fusion and Texture Analysis of PET/MR Imaging.
Vallières M; Freeman CR; Skamene SR; Naqa IE
Med Phys; 2012 Jun; 39(6Part3):3615. PubMed ID: 28517427
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of multimodality texture-based prediction models via optimization of PET and MR image acquisition protocols: a proof of concept.
Vallières M; Laberge S; Diamant A; El Naqa I
Phys Med Biol; 2017 Oct; 62(22):8536-8565. PubMed ID: 28872054
[TBL] [Abstract][Full Text] [Related]
4. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
5. Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.
Sheen H; Kim W; Byun BH; Kong CB; Song WS; Cho WH; Lim I; Lim SM; Woo SK
PLoS One; 2019; 14(11):e0225242. PubMed ID: 31765423
[TBL] [Abstract][Full Text] [Related]
6. Fusion of FDG-PET Image and Clinical Features for Prediction of Lung Metastasis in Soft Tissue Sarcomas.
Deng J; Zeng W; Shi Y; Kong W; Guo S
Comput Math Methods Med; 2020; 2020():8153295. PubMed ID: 32454885
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
8. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Fendler WP; Chalkidis RP; Ilhan H; Knösel T; Herrmann K; Issels RD; Bartenstein P; Cyran CC; Lindner LH; Hacker M
Eur Radiol; 2015 Aug; 25(8):2214-21. PubMed ID: 25693667
[TBL] [Abstract][Full Text] [Related]
10. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Yen TC; Chang YC; Chan SC; Chang JT; Hsu CH; Lin KJ; Lin WJ; Fu YK; Ng SH
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):541-8. PubMed ID: 15625603
[TBL] [Abstract][Full Text] [Related]
11. PET/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma.
Zhao W; Huang X; Wang G; Guo J
Cancer Imaging; 2022 Jan; 22(1):7. PubMed ID: 35022071
[TBL] [Abstract][Full Text] [Related]
12. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of
Zhang A; Meng X; Yao Y; Zhou X; Yan S; Fei W; Zhou N; Zhang Y; Kong H; Li N
J Magn Reson Imaging; 2023 May; 57(5):1367-1375. PubMed ID: 36066210
[TBL] [Abstract][Full Text] [Related]
14. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of pre-therapy
Anthony GJ; Cunliffe A; Castillo R; Pham N; Guerrero T; Armato SG; Al-Hallaq HA
Med Phys; 2017 Jul; 44(7):3686-3694. PubMed ID: 28422299
[TBL] [Abstract][Full Text] [Related]
16. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
[TBL] [Abstract][Full Text] [Related]
17. Tumor grade in soft-tissue sarcoma: Prediction with magnetic resonance imaging texture analysis.
Hong JH; Jee WH; Jung CK; Chung YG
Medicine (Baltimore); 2020 Jul; 99(27):e20880. PubMed ID: 32629676
[TBL] [Abstract][Full Text] [Related]
18. Tumor grading of soft tissue sarcomas using MRI-based radiomics.
Peeken JC; Spraker MB; Knebel C; Dapper H; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; von Eisenhart-Rothe R; Nüsslin F; Mayr NA; Nyflot MJ; Combs SE
EBioMedicine; 2019 Oct; 48():332-340. PubMed ID: 31522983
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
20. T
Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
